Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free SPEC Stock Alerts

Spectaire (SPEC) Competitors

Spectaire logo
$0.0003 0.00 (0.00%)
As of 07/2/2026
Compare

SPEC vs. THMO, HTGMQ, PRENW, QSIAW, and SMAPW

Should you buy Spectaire stock or one of its competitors? MarketBeat compares Spectaire with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Spectaire include ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), Prenetics Global (PRENW), Quantum-Si (QSIAW), and SportsMap Tech Acquisition (SMAPW). These companies are all part of the "measuring and control equipment" industry.

How does Spectaire compare to ThermoGenesis?

Spectaire (NASDAQ:SPEC) and ThermoGenesis (NASDAQ:THMO) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

In the previous week, Spectaire's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
Spectaire Neutral
ThermoGenesis Neutral

Spectaire has higher earnings, but lower revenue than ThermoGenesis. Spectaire is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SpectaireN/AN/A$8.95M-$0.30N/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Spectaire has a beta of -6.36, indicating that its share price is 736% less volatile than the broader market. Comparatively, ThermoGenesis has a beta of 1.13, indicating that its share price is 13% more volatile than the broader market.

26.5% of Spectaire shares are owned by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are owned by institutional investors. 25.4% of Spectaire shares are owned by company insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

ThermoGenesis' return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SpectaireN/A -81.22% 304.57%
ThermoGenesis N/A N/A N/A

Summary

ThermoGenesis beats Spectaire on 5 of the 9 factors compared between the two stocks.

How does Spectaire compare to HTG Molecular Diagnostics?

Spectaire (NASDAQ:SPEC) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

HTG Molecular Diagnostics' return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SpectaireN/A -81.22% 304.57%
HTG Molecular Diagnostics N/A N/A N/A

Spectaire has a beta of -6.36, indicating that its stock price is 736% less volatile than the broader market. Comparatively, HTG Molecular Diagnostics has a beta of 3.06, indicating that its stock price is 206% more volatile than the broader market.

26.5% of Spectaire shares are owned by institutional investors. 25.4% of Spectaire shares are owned by company insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Spectaire has higher earnings, but lower revenue than HTG Molecular Diagnostics. Spectaire is trading at a lower price-to-earnings ratio than HTG Molecular Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SpectaireN/AN/A$8.95M-$0.30N/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

In the previous week, Spectaire's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
Spectaire Neutral
HTG Molecular Diagnostics Neutral

Summary

Spectaire beats HTG Molecular Diagnostics on 5 of the 9 factors compared between the two stocks.

How does Spectaire compare to Prenetics Global?

Spectaire (NASDAQ:SPEC) and Prenetics Global (NASDAQ:PRENW) are both measuring and control equipment companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

In the previous week, Spectaire's average media sentiment score of 0.00 equaled Prenetics Global'saverage media sentiment score.

Company Overall Sentiment
Spectaire Neutral
Prenetics Global Neutral

26.5% of Spectaire shares are owned by institutional investors. 25.4% of Spectaire shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Spectaire has higher earnings, but lower revenue than Prenetics Global.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SpectaireN/AN/A$8.95M-$0.30N/A
Prenetics Global$120.07MN/AN/AN/AN/A

Prenetics Global's return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SpectaireN/A -81.22% 304.57%
Prenetics Global N/A N/A N/A

Summary

Spectaire beats Prenetics Global on 3 of the 5 factors compared between the two stocks.

How does Spectaire compare to Quantum-Si?

Spectaire (NASDAQ:SPEC) and Quantum-Si (NASDAQ:QSIAW) are both measuring and control equipment companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Quantum-Si's return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SpectaireN/A -81.22% 304.57%
Quantum-Si N/A N/A N/A

26.5% of Spectaire shares are owned by institutional investors. 25.4% of Spectaire shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Spectaire has higher earnings, but lower revenue than Quantum-Si.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SpectaireN/AN/A$8.95M-$0.30N/A
Quantum-Si$1.85MN/AN/AN/AN/A

In the previous week, Spectaire's average media sentiment score of 0.00 equaled Quantum-Si'saverage media sentiment score.

Company Overall Sentiment
Spectaire Neutral
Quantum-Si Neutral

Summary

Spectaire beats Quantum-Si on 3 of the 5 factors compared between the two stocks.

How does Spectaire compare to SportsMap Tech Acquisition?

SportsMap Tech Acquisition (NASDAQ:SMAPW) and Spectaire (NASDAQ:SPEC) are both measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

26.5% of Spectaire shares are held by institutional investors. 25.4% of Spectaire shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

SportsMap Tech Acquisition's return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SportsMap Tech AcquisitionN/A N/A N/A
Spectaire N/A -81.22%304.57%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SportsMap Tech AcquisitionN/AN/AN/AN/AN/A
SpectaireN/AN/A$8.95M-$0.30N/A

In the previous week, SportsMap Tech Acquisition's average media sentiment score of 0.00 equaled Spectaire'saverage media sentiment score.

Company Overall Sentiment
SportsMap Tech Acquisition Neutral
Spectaire Neutral

Summary

Spectaire beats SportsMap Tech Acquisition on 3 of the 4 factors compared between the two stocks.

Get Spectaire News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPEC vs. The Competition

Export
MetricSpectaireMeasuring & controlling devices IndustryComputer SectorNASDAQ Exchange
Market Cap$6K$94.59M$38.47B$12.48B
Dividend YieldN/A11.15%3.17%6.52%
P/E Ratio0.005.97170.2624.69
Price / SalesN/A8.72601.3098.72
Price / CashN/A8.3845.6449.23
Price / Book0.001.279.636.49
Net Income$8.95M$7.16M$1.07B$336.25M
7 Day PerformanceN/A-0.47%0.97%1.69%
1 Month PerformanceN/A-2.27%0.23%3.81%
1 Year PerformanceN/A123.81%143.56%23.90%

Spectaire Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPEC
Spectaire
N/A$0.00
flat		N/AN/A$6KN/AN/A8
THMO
ThermoGenesis
N/AN/AN/AN/A$1K$9.61MN/A40
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90
PRENW
Prenetics Global
N/A$0.01
flat		N/A-64.5%$0.00$120.07MN/A1
QSIAW
Quantum-Si
N/A$0.01
flat		N/AN/A$0.00$1.85MN/A150

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SPEC) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel